RUNX3 Downregulation in Human Lung Adenocarcinoma is Independent of p53, EGFR or KRAS Status

Lung tissue regeneration after induced injury in Runx3 KO mice

(2010) Jong-Min Lee et al.   CELL AND TISSUE RESEARCH

Runx3 is required for the differentiation of lung epithelial cells and suppression of lung cancer

(2010) K-S Lee et al.   ONCOGENE

EGFR/KRAS/BRAF Mutations in Primary Lung Adenocarcinomas and Corresponding Locoregional Lymph Node Metastases

(2009) K. Schmid et al.   CLINICAL CANCER RESEARCH

Runx3 expression in gastrointestinal tract epithelium: resolving the controversy

(2009) K Ito et al.   ONCOGENE

RUNX3 Has an Oncogenic Role in Head and Neck Cancer

(2009) Takaaki Tsunematsu et al.   PLoS One

EGFR and KRAS Mutations in Patients With Adenocarcinoma of the Lung

(2009) Tae Won Jang et al.   KOREAN JOURNAL OF INTERNAL MEDICINE

RUNX3 Attenuates β-Catenin/T Cell Factors in Intestinal Tumorigenesis

(2008) Kosei Ito et al.   CANCER CELL

Epigenetic alteration of Wnt pathway antagonists in progressive glandular neoplasia of the lung

(2008) Julien D.F. Licchesi et al.   CARCINOGENESIS

A Personalized Approach to Cancer Treatment: How Biomarkers Can Help

(2008) M. J. Duffy et al.   CLINICAL CHEMISTRY

TRARESA: a tissue microarray-based hospital system for biomarker validation and discovery

(2008) Kakoli Das et al.   PATHOLOGY

Genetic Mapping in Human Disease

(2008) D. Altshuler et al.   SCIENCE